Lv21
180 积分 2020-10-07 加入
FRONTIER-2: A phase 2b, long-term extension, dose-ranging study of oral JNJ-77242113 for the treatment of moderate-to-severe plaque psoriasis
6小时前
待确认
An Oral Interleukin-23–Receptor Antagonist Peptide for Plaque Psoriasis
6小时前
已完结
mRNA Display Pipeline for Protein Biosensor Construction
3天前
已完结
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
1个月前
已完结
Generation and Characterization of Mirikizumab, a Humanized Monoclonal Antibody Targeting the p19 Subunit of IL-23
1个月前
已完结
CTLA-4-expressing ILC3s restrain interleukin-23-mediated inflammation
1个月前
已完结
Cyclic Peptide Screening Methods for Preclinical Drug Discovery
2个月前
已完结
Imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial
2个月前
已完结
From exploring cancer and virus targets to discovering active peptides through mRNA display
2个月前
已完结
Purification and activity evaluation of novel anti-inflammatory peptides from pearl oyster (Pinctada martensii) hydrolysates
2个月前
已完结
皖公网安备34019202002308
